HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Letrozole (Femara)

A triazole and benzonitrile derivative that is a selective non-steroidal aromatase inhibitor, similar to ANASTROZOLE. It is used in the treatment of metastatic or locally advanced breast cancer in postmenopausal women.
Also Known As:
Femara; 4,4'-(1H-1,2,4-triazol-1-yl-methylene)-bis(benzonitrile); CGS 20267; CGS-20267; Fémara; CGS20267; Benzonitrile, 4,4'-(1H-1,2,4-triazol-1-ylmethylene)bis-
Networked: 2111 relevant articles (352 outcomes, 671 trials/studies)

Relationship Network

Drug Context: Research Results

Experts

1. Goldhirsch, Aron: 32 articles (02/2021 - 12/2005)
2. Goss, Paul E: 30 articles (02/2022 - 06/2002)
3. Gelber, Richard D: 28 articles (02/2021 - 12/2005)
4. Colleoni, Marco: 26 articles (02/2021 - 02/2007)
5. Ingle, James N: 25 articles (02/2022 - 09/2003)
6. Coates, Alan S: 24 articles (02/2021 - 12/2005)
7. Regan, Meredith M: 24 articles (02/2021 - 09/2007)
8. Thürlimann, Beat: 24 articles (02/2021 - 12/2005)
9. Dixon, J Michael: 23 articles (01/2020 - 06/2002)
10. Evans, Dean B: 22 articles (10/2012 - 10/2003)

Related Diseases

1. Breast Neoplasms (Breast Cancer)
2. Neoplasms (Cancer)
3. Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal)
4. Neoplasm Metastasis (Metastasis)
5. Infertility (Sterility)

Related Drugs and Biologics

1. Tamoxifen
2. Aromatase Inhibitors
3. Hormones (Hormone)
4. Anastrozole (Arimidex)
5. palbociclib
6. Estrogen Receptors
7. exemestane (Aromasin)
8. Clomiphene (Clomifene)
9. ribociclib
10. ErbB Receptors (EGF Receptor)

Related Therapies and Procedures

1. Therapeutics
2. Drug Therapy (Chemotherapy)
3. Neoadjuvant Therapy
4. Aftercare (After-Treatment)
5. Chemoprevention